Mycobacterium tuberculosis is the most prolific and poorly understood pathogen of humans. It is estimated that one-third of the world's population is infected with M. tuberculosis and that each year 3 million people die of this disease (28) . In an effort to control the threat of tuberculosis, attenuated bacillus Calmette-Guérin (BCG) has been used as a live attenuated vaccine. BCG is an attenuated derivative of Mycobacterium bovis, a virulent tubercle bacillus very closely related to M. tuberculosis (13, 22) . BCG has been used for over 5 decades to immunize over 3 billion people in immunization programs against tuberculosis. While its protective efficacy against tuberculosis has been highly variable, by recent meta-analysis estimates, on average the BCG vaccine reduced the overall risks of tuberculosis by 50% and serious forms of this disease by 70 to 80% (7) . As a safe, inexpensive vaccine with potent nonspecific immunostimulatory properties, BCG has more recently been proposed and developed as a live recombinant vehicle for new multivalent vaccines against other diseases (36, 37) . The original BCG Pasteur strain was developed by 230 serial passages in liquid culture and has never been shown to revert to virulence in animals, indicating that the attenuating mutation(s) in BCG are stable deletions and/or multiple mutations which do not readily revert. While physiological differences between BCG and M. tuberculosis and M. bovis have been noted (31, 38, 40) , the attenuating mutations which arose during serial passage of the original BCG strain have never been identified.
In this study, we used genomic subtraction (39) to identify gross genomic differences between avirulent BCG and virulent M. bovis and M. tuberculosis strains. By this approach, three genomic regions of difference were identified, cloned, and sequenced. Complete sequence comparisons of each region from a virulent M. bovis strain and the BCG Connaught substrain revealed the precise junctions for each region of difference. RD3, a 9.3-kb genomic segment absent from all BCG substrains, was found in virulent laboratory strains of M. bovis and M. tuberculosis, but only in a minority of M. tuberculosis clinical isolates tested. RD2, a 10.7-kb DNA segment containing a novel repetitive element and the previously identified mpt-64 gene, was found to be conserved in all virulent laboratory and clinical M. bovis and M. tuberculosis strains tested and was deleted only from BCG substrains derived from the BCG Pasteur strain after 1925, indicating that the deletion of RD2 was not a feature of the original BCG.
A 9.5-kb DNA segment, designated RD1, was absent from all BCG substrains but conserved in all virulent laboratory and clinical strains of M. bovis and M. tuberculosis tested, suggesting that the deletion of RD1 was an original attenuating mutation which arose in the derivation of BCG. The reintroduction of RD1 into BCG resulted in the repression of at least 10 proteins and induced expression of at least three additional proteins, yielding a protein expression profile almost identical to that of virulent M. bovis and M. tuberculosis. These data suggest that BCG lacks regulatory control over multiple genetic loci and is consistent with the involvement of RD1-encoded gene product(s) in a global regulatory mechanism associated with virulence. These findings may facilitate new approaches for the discovery and development of new antitu-berculosis drugs, vaccines, and novel diagnostic tests capable of distinguishing tuberculosis-infected individuals from BCG-vaccinated persons.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, and growth conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . Mycobacteria were maintained either in 7H9 medium (Difco, Detroit, Mich.) supplemented with OADC (BBL, Cockeysville, Md.) and 0.04% Tween 80 or on 7H10 agar supplemented with OADC. Escherichia coli strains were maintained on L agar (Difco) or in Luria broth (Difco). As necessary, media were supplemented with 20 g of kanamycin per ml or 100 g of carbenicillin per ml. Bacteria were stored as frozen cultures at Ϫ80ЊC in either 7H9 or Luria broth containing 20% glycerol.
Preparation of nucleic acids and subtracted DNA probes. High-molecularweight (HMW) chromosomal DNA was prepared from mycobacteria by diluting a late-log-phase culture 1:10 into a liter of 7H9 medium containing 1.5% glycine and continuing incubation at 37ЊC for 4 to 5 days. Cells were harvested by centrifugation (5,000 ϫ g), washed once in Tris-EDTA buffer (TE; pH 8.0) (29) , and resuspended in 4 ml of 25% sucrose in 10ϫ TE. Lysozyme (100 g/ml) was added, and the preparation was incubated at 37ЊC for 2 h, with the subsequent addition of 100 g of proteinase K and N-lauroylsarcosine to final concentration of 1%. After overnight incubation at 65ЊC, the mixture was extracted four times with chloroform-isoamyl alcohol (24:1), once with phenol-chloroform (1:1), and twice more with chloroform-isoamyl alcohol. The resulting HMW DNA was centrifuged through a CsCl gradient by the method of Hull et al. (19) and subsequently dialyzed against 4 1-liter volumes of TE.
Subtracted DNA probes were generated by the method of Straus and Ausubel (39) . BCG Connaught HMW chromosomal DNA was sheared by passage through a 22-gauge needle to an average size of 3 to 10 kb, as determined by agarose gel electrophoresis. This DNA was biotinylated with Photobiotin (Clontech Laboratories, Inc., Palo Alto, Calif.) by the method of Straus and Ausubel (39) . Sheared and biotinylated BCG Connaught DNA was used in a 10:1 excess for each round of subtraction. Wild-type M. tuberculosis H37Rv HMW DNA was digested with Sau3AI to an average size of 1 kb and hybridized to biotinylated BCG Connaught DNA for 18 h at 65ЊC in 1 M NaCl. Biotinylated DNA was removed from the hybridization mixture binding to avidin-coated beads, with subsequent filtration as previously described (39) . After 5 cycles of subtraction, Sau3AI adapters were ligated to the subtraction products and amplified by 35 cycles of PCR as previously described (39) . Radiolabeled probes were generated by using an adapter oligonucleotide primer and incorporating [␣-32 P]dCTP (New England Nuclear, Boston, Mass.) with Klenow enzyme.
Recombinant DNA methods. An M. bovis cosmid library was constructed by the insertion of partially Sau3AI-digested HMW M. bovis chromosomal DNA into the BamHI site of sCOS. Recombinant clones were packaged in vitro with Packagene extracts (Promega Corp., Madison, Wis.) and used to infect E. coli NM554 (Stratagene, La Jolla, Calif.). Recombinant cosmid clones were transferred to charge-modified nylon circular membranes, and membranes were prepared by the method of Grunstein and Hogness (14) . Then these membranes were hybridized with radiolabeled products generated by subtraction between BCG and H37Rv DNAs. Cosmid DNA was prepared from selected clones by the method of Birnboim and Doly (5) . Restriction fragments from each of the three cosmids representing individual regions were subcloned into pGEM7z or pGEM5z for deletion construction and DNA sequencing. Plasmid DNA for sequencing was prepared by using Qiagen mini columns (QIAGEN, Inc., Chatsworth, Calif.). Nested deletions were prepared by using the Erase-a-Base system (Promega Corp.) (16) . Membrane filters for the analysis of clinical isolates were obtained from B. Kreiswirth at the Public Health Research Institute, New York, N.Y.
The construction of recombinant BCG carrying RD1 was made by electroporation of pGM910 into BCG Brazil (34) . pGM910 was made by two successive cloning steps. The first was the cloning of a HindIII-EcoRI fragment from pGM592 into the HindIII-to-EcoRI sites of pMV306 (36) . The EcoRI fragment of pGM896 was inserted into the only remaining EcoRI site, and the orientation Labeling and 2-D electrophoretic analysis of mycobacterial proteins. Tenmilliliter cultures of mycobacteria (optical density at 540 nm ϭ 0.1) were labeled by the addition of 125 Ci (1 Ci ϭ 37 GBq) of L- [ 35 S]methionine (NEN). After incubation at 37ЊC for 1 h, unlabeled L-methionine was added to 10 mM, and the culture was cooled on ice for 10 min. The culture was harvested by centrifugation and resuspended in 300 l of distilled H 2 O with 1 mM phenylmethylsulfonyl fluoride. The culture was transferred to a 0.5-ml tube containing 300 mg of 0.1-mm-diameter glass beads and lysed by shaking in a Mini Bead-Beater apparatus (BioSpec Products, Bartlesville, Okla.) at high speed for 3 min. Lysates were mixed with isoelectric focusing buffer and analyzed by two-dimensional (2-D) gel electrophoresis (11, 27) .
DNA sequencing and computer analysis. DNA sequencing was carried out on an Applied Biosystems, Inc., automated sequencer by the dye termination method, and the sequence was edited by using the manufacturer's software. Sequence assembly and further editing were done with Sequencher DNA analysis software (Genecodes, Ann Arbor, Mich.). TBLASTN and FASTA sequence homology analyses were performed by using the National Center for Biotechnology Information BLAST network service.
Nucleotide sequence accession number. The sequence data from which the information presented was derived were submitted to GenBank. A small gap of several hundred base pairs which remained refractory to sequencing exists toward the 3Ј end of RD3; therefore, there are two accession numbers for it. The sequences of RD3 and the adjacent BCG homologous sequence have been deposited under accession numbers U35017 and U35018 and U35021, respectively. The sequence of M. bovis RD2 and the flanking BCG homologous sequence have been deposited under accession numbers U34849 and U35020, respectively. The sequence of M. bovis RD1 and the BCG homologous adjacent sequence have been deposited under accession numbers U34848 and U35019, respectively.
RESULTS
Genomic subtraction between BCG and M. tuberculosis. Subtractive hybridization between avirulent BCG Connaught and virulent M. tuberculosis H37Rv was used to isolate sequences present in virulent mycobacteria and absent from BCG. The specificity of the subtracted and amplified H37Rv DNA as a probe was examined by Southern blot analysis with BCG and virulent M. tuberculosis and M. bovis chromosomal DNAs (Fig.  1) . The subtracted radiolabeled probe failed to hybridize with BCG ( Fig. 1 , lane 5), indicating that biotinylated BCG DNA and BCG homologous sequences were efficiently removed and that sequences of difference were both enriched for and amplified. The subtracted probe did hybridize strongly with M. bovis ( Fig. 1 , lanes 1 and 6) and M. tuberculosis (lanes 2 to 4 and 7 to 9). M. tuberculosis H37Ra (Fig. 1, lanes 2 and 7) produced a banding pattern similar to that of virulent M. tuberculosis Erdman (lanes 4 and 9) and H37Rv (lanes 3 and 8). Subtractive hybridization between H37Rv and H37Ra did not yield a probe that could distinguish between these two strains, suggesting that the genetic differences between H37Rv and H37Ra are point mutations or small deletions undetectable by this subtractive method. Comparisons of the hybridization patterns of restricted genomic DNA between M. bovis and M. tuberculosis revealed a subset of common restriction fragments hybridizing to the labeled subtracted probe. M. bovis exhibited a less complex hybridization pattern with the subtracted probe than did M. tuberculosis. Additional M. tuberculosis DNA observed to hybridize with the subtracted probe may reflect restriction fragment length polymorphisms or may indicate more gross genetic differences between M. bovis and M. tuberculosis.
Molecular cloning and analysis of M. bovis genomic regions absent from BCG. To isolate and clone the genetic differences between M. bovis and BCG, a cosmid library of M. bovis chromosomal DNA was constructed in sCOS and screened with a radiolabeled BCG Connaught-H37Rv subtraction product as the probe. From 600 independent cosmids, 18 reactive clones were identified and characterized by restriction endonuclease and Southern hybridization analyses. It was possible to group the 18 independent cosmid clones into three groups on the basis of the presence of coincident EcoRI and NotI restriction fragments hybridizing to the subtracted probe. These three cosmid groups presumably represented three distinct genomic regions of difference between BCG and M. bovis. These regions were subsequently designated M. bovis RD1, RD2, and RD3 and contained in their entirety in cosmids pGM540, pGM538, and pGM542, respectively. Each representative cosmid was used as a probe for Southern blot analysis of chromosomal DNA restriction digests with EcoRI since sCOS has two EcoRI sites that flank the BamHI cloning site. The patterns obtained by this analysis were compared with restriction fragment patterns obtained for each cosmid to confirm that the selected cosmids were not composed of scrambled discontinuous genomic segments and to identify terminal fragments in each cosmid insert. Fragments from each of the three cosmids identified by hybridization with the subtracted probe were subcloned into pGEM7z or pGEM5z for the construction of nested deletions and DNA sequencing. Significant subclones from which all the deletion constructs for sequencing were made are described in Table 1. Table 2 summarizes the sequence analysis by identifying open reading frames (ORFs), possible ribosomal binding sites, molecular weights and pIs of potential encoded proteins, and possible homologous proteins derived from six-frame translations of the nonredundant DNA database. Physical maps of the three M. bovis regions, derived from DNA sequence data, are presented in Fig. 2 . Homologous chromosomal fragments in BCG were identified by Southern blotting, with labeled cosmids carrying each region of difference as probes. Restriction fragments that were polymorphic in comparison to M. bovis were presumed to carry DNA representing the junctions of the chromosomal regions of difference. These junction fragments were subsequently cloned and sequenced. The precise limits of the regions of difference were determined by comparing the sequences from the BCG chromosome in plasmids pPS1000, pPS1007, and pGM906 with the sequences in RD1, RD2, and RD3, respectively (Fig.  3) .
Analysis of M. bovis RD3. M. bovis RD3 contains at least 10 ORFs (Fig. 2) with GC-rich codon usage profiles consistent with those of expressed M. tuberculosis genes. Possible homology to Streptomyces phage phi-C31 were observed for ORFs 3D and 3E. ORFs 3I, 3J, and 3K exhibited highly significant homologies (Table 2) to ORFs in the sequenced M. leprae cosmid B1170. An ORF straddling the BCG deletion junction of RD3 shows striking homology to the reported sequence of a region encoding the M. tuberculosis mce gene. This region was previously reported to encode genes for a putative invasin and macrophage survival determinant. However, the extent of the homology between ORF3A and the mce region sequence reported by Arruda et al. (2) is limited to an internal Sau3AI fragment in the previously reported sequence (GenBank accession number X70901), suggesting that restriction fragment scrambling occurred in the construction of the plasmid library. Since the cosmids generated in this study were also generated by partial Sau3AI digests, we confirmed the fidelity of our sequence by sequencing an independently cloned restriction fragment from M. bovis and BCG. It has been confirmed that the previously reported sequence is derived from scrambled restriction fragments (28a). However, the sequence of one ORF (bp 181 to 807), that of the mce gene, is not affected by this scrambling; the downstream region potentially encoding a determinant for macrophage survival (from bp 866 to the end of the fragment) is affected. Southern blot analysis indicated the presence of a repetitive element located in the BCG homologous sequence near the 5Ј end of RD3. This repeat is present in three to four copies in BCG, M. bovis, and M. tuberculosis (data not shown). The core sequence of this repeat has not been determined. By using the NotI fragment of pGM802 as an RD3-specific probe, RD3 was shown to be present in M. tuberculosis Erdman and M. bovis and absent from BCG (Fig. 4 and Fig. 5 ). Figure 4 shows that RD3 is also absent from BCG substrains Connaught, Pasteur, and Brazil. Similar Southern blots with the 1. (Fig. 2) . Database homology searches with derived protein sequences from predicted ORFs revealed a number of interesting homologies. The derived peptide sequence of ORF2C bears striking similarity over its entire length to the IciA protein of E. coli (17, 20, 21, 41) and similarities of lesser degree to other members of the lysR family of transcriptional regulators. Each lysR family member possesses a helix-turnhelix motif (17) , and this feature is also conserved in the putative protein encoded by ORF2C (data not shown). ORF2F potentially encodes a protein with strong homology to a Salmonella typhimurium ribonucleotide diphosphate reductase that catalyzes the reduction of ribonucleosides to their deoxy derivatives. The derived peptide sequence from ORF2H exhibits limited homology to the GabP aromatic amino acid permease of E. coli, while ORF2L has homology to a hypothetical protein encoded by a hypothetical ORF near the gene encoding GabP. ORF2G encodes the previously identified Mpt-64 protein antigen, which was investigated as an M. tuberculosis-specific secreted antigen not expressed in BCG (24) .
Southern blot analysis with a probe from between bp 7,591 and 9,945 of RD2 identified a repetitive element present in 10 or more copies on the chromosomes of BCG, M. tuberculosis, and M. bovis (Fig. 6) . The presence of this repetitive element confounded the initial characterization of RD2 by restriction mapping and Southern blotting and necessitated the use of flanking sequences as region-specific probes. RD2 contains several additional small repeated sequences; the most notable are two imperfect direct repeats (at bp 2,864 to 2,888 and 13,652 to 13,675) (Fig. 3 ) positioned exactly at the deletion breakpoint of the M. bovis sequence. These sequences have the potential for forming secondary structures, providing a possible mechanism for the evolution of this deletion (3, 10, 18, 23, 25, 26) . The presence of RD2 in several BCG substrains was examined by using probes for the 3Ј portion (a PstI fragment containing mpt-64 from pGM590) and the 5Ј portion (an EcoRI-SphI fragment [coordinates bp 3,484 to 6,262]) of RD2 ( Fig. 4B and C, respectively) . The results demonstrate that RD2 is present in M. tuberculosis Erdman, M. bovis, and BCG Brazil. RD2 was also shown to be present in BCG Japanese (data not shown). Also evident in Fig. 4 is an apparent restriction fragment length polymorphism between M. bovis and M. tuberculosis; this difference is also evident in BCG substrains carrying RD2. Southern blot analyses with two distinct probes for both the 5Ј and 3Ј ends of the central EcoRI fragment of RD2 show that the M. bovis EcoRI fragment is about 2 kb smaller than its M. tuberculosis homolog (Fig. 4B and C) . With the exception of the 5Ј end, RD2-specific probes failed to hybridize with M. smegmatis or M. avium (Fig. 5B ). An RD2-specific probe with flanking EcoRI and SphI sites (bp 3,484 to 6,262) that includes iciA and two surrounding ORFs gave a faintly discernible band that may be an iciA homolog in these species (Fig. 5, lanes 3 and 4) . RD2 was found in 80 of 80 clinical isolates of M. tuberculosis, Erdman, H37Rv, and M. bovis. These data suggest that the deletion of RD2 is not a mutation which arose during the original derivation of BCG, but they do not rule out a possible role for RD2 in virulence. examined by Southern hybridization with the EcoRI-XbaI fragment from pPS1003 as the probe (Fig. 4A and 5A) . RD1 is present in M. tuberculosis Erdman and M. bovis but absent from BCG Connaught, Pasteur, and Brazil. RD1 is also absent from BCG Tice, Japanese, and Danish (data not shown). RD1 homologous sequences were not found in M. smegmatis and M. avium when examined by Southern hybridization under moderately stringent conditions (6ϫ SSC [1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate], 70ЊC) (Fig. 5A) . With the EcoRIXbaI fragment from pPS1003 as the probe, RD1 was found to Fig. 2 and Table 2 ). ORF1A has a 47-bp direct repeat immediately preceding the translational start codon that is homologous to the region upstream of the start codon of mtrB. mtrB has been implicated as part of a two-component signal transduction system in mycobacteria whose role in an active regulatory mechanism is yet to be reported (9) . ORF1B has 22% sequence homology to an ORF downstream from the M. tuberculosis 65-kDa antigen (32, 33) . A small 287-bp ORF, designated ORF1C, was recognized as the previously identified esat6 gene. The esat6 gene product is a small secreted protein under investigation as an immunogen eliciting immunity to M. tuberculosis (1, 6, 15 ). An ORF, designated ORF1J, with significant homology to a Bacillus subtilis subtilisin was identified in DNA flanking RD1.
Analysis of the effects of regions of difference on BCG gene expression. To evaluate RD2-encoded proteins, 2-D gel electrophoretic analysis was used. A comparison of BCG Brazil (containing RD2) with BCG Connaught revealed three obvious protein differences which distinguish these two substrains (Fig. 7) . The molecular weights and pIs of these proteins are consistent with the molecular weights and pIs predicted for proteins encoded by ORFs 2D, 2F, 2G, 2I, and 2J. Because BCG Brazil contains a complete RD2, it was used for subsequent comparisons with virulent tubercle bacilli. Despite the identification of sizable genomic regions absent from BCG (RD1 and RD3) but present in M. bovis and M. tuberculosis, BCG expresses at least 10 additional proteins and appears to express higher levels of many proteins.
In order to characterize the effect of reintroducing RD1 into BCG, the entire region was cloned into pMV306 (37), a sitespecific, integrating, mycobacterial shuttle vector. The resulting clone, pGM910 (Table 1) , was then introduced into the Brazil strain of BCG (35) . The resulting recombinant BCG was compared with BCG, M. tuberculosis, and M. bovis by 2-D protein gel electrophoresis. As seen in Fig. 8, M. bovis and M. tuberculosis show strikingly similar protein profiles. However, M. tuberculosis expresses a low-molecular-weight protein not observed in M. bovis or BCG, while BCG and M. bovis express an acidic protein of approximately 20 kDa that is not observed in M. tuberculosis. Wild-type M. bovis and BCG::RD1 show identical profiles, with the exception of a single low-molecularweight acidic protein (Fig. 8C) . Two proteins which are apparently upregulated severalfold (Fig. 8A [arrows] ) are consistent with the known isoelectric points, molecular weights, and expression levels of Hsp60 and Hsp70. Consistent with this finding is the result that gene fusions driven from the Hsp60 promoter with firefly luciferase are threefold higher in BCG than those in M. tuberculosis (data not shown). Additionally, BCG::RD1 shows the disappearance of at least 10 other proteins. BCG::RD1 also expresses several additional proteins (Fig. 8B ) that may be RD1-encoded proteins; the molecular weight and pI of one of them are consistent with those of the esat6 gene product. There are a number of very small ORFs in RD1 that could encode low-molecular-weight proteins but are not shown as ORFs in Fig. 2 . An additional low-molecularweight protein seen in M. bovis and M. tuberculosis, not in either BCG::RD1 or BCG Brazil, may be an RD3-encoded protein, since RD3 is the only region of difference between M. bovis, M. tuberculosis, and BCG::RD1. 
DISCUSSION
Genomic subtractive hybridization was used to identify gross genetic differences between avirulent BCG and virulent M. tuberculosis and M. bovis. M. tuberculosis and M. bovis are closely related members of the tuberculosis complex, and because of their genetic identity, it has been suggested that they be considered strains of the same species (13, 22) . The genomic subtraction between BCG Connaught and M. tuberculosis H37Rv performed in this study would be expected to identify gross genetic differences which might exist between BCG and M. tuberculosis and additional differences which might exist between M. bovis and M. tuberculosis. Since BCG is derived from M. bovis and the subtracted probe revealed fewer apparent differences between BCG and M. bovis, we first focused on the genetic differences between BCG and virulent M. bovis. Three large chromosomal regions present in virulent M. bovis but absent from BCG Connaught were identified. Southern hybridization showed all three regions to be present in virulent laboratory strains of M. tuberculosis (H37Rv and Erdman) but likely absent from M. avium and M. smegmatis, indicating that these genetic differences were likely unique to tuberculosis complex organisms. RD1 and RD3 were completely absent from all BCG substrains examined.
The origin of the 9.3-kb RD3 is not clear, since it appears to be present in laboratory strains of M. bovis and M. tuberculosis but absent from the great majority of clinical isolates. Limited homologies to some Streptomyces phage genes may suggest an origin for this polymorphic region, but a role for RD3 in virulence is doubtful. The presence of homologies to Streptomyces phages raises the possibility of phage-mediated genetic transfer between Streptomyces species and pathogenic mycobacteria.
The finding that RD2 is present in some BCG strains and absent from others indicates heterogeneity among BCG substrains and confirms previous immunological findings focusing on the MPB64 (Mpt-64) protein antigen. MPB64 was thought to be an M. tuberculosis-specific antigen, but subsequent analysis of BCG substrains revealed heterogeneity among them with respect to the presence and expression of the mpt-64 gene (8, 24) . BCG Brazil and the Japanese and Russian substrains, all of which express the Mpt-64 antigen encoded by ORF2G, were derived from the original BCG Pasteur strain prior to 1925. RD2 is apparently absent from BCG substrains derived from the original BCG Pasteur strain after 1925; therefore, a significant change in the BCG Pasteur strain seed lot occurred after 1925 and prior to 1934, when the next BCG substrain, Tice, was derived. A mechanism by which RD2 may have been deleted is provided by the presence of numerous small repeated sequences existing at the boundaries of RD2. The formation of hairpin secondary structures composed of indirect repeats may have resulted in the deletion of this region (3, 10, 18, 23, 25, 26) . Phenotypic differences between BCG substrains which differ by the presence or absence of RD2 are not readily apparent but have not been evaluated in depth. It should also be noted that BCG substrains carrying a complete RD2 (e.g., Brazil and Japan) have been widely used as tuberculosis vaccines, as have BCG substrains lacking RD2. However, differences in vaccine efficacy which might be associated with the presence or absence of RD2 cannot be ascertained because differences in BCG vaccine efficacy associated with BCG substrains have never been consistently observed (8) .
Homology searches of the nonredundant genetic database provided few clues to the function of potential coding regions. Of the putative ORFs encoded in RD2, the homology between ORF2C and IciA is most striking. In E. coli, IciA negatively controls the initiation of chromosomal replication and is a member of the LysR family of regulatory proteins (17, 20, 21, 30, 41) . The helix-turn-helix motif of the IciA homologous protein is 100% conserved at the amino acid level, indicating that this protein probably binds DNA. Although IciA is a member of the LysR family, it has been shown to inhibit the initiation of chromosomal DNA replication by binding at the origin of replication and has yet to be implicated in transcriptional regulation (17, 20, 21, 41) . RD2 also carries a novel sequence that is present in multiple copies on the chromosome and capable of differentiating between IS6110 types when used as a probe. We are presently evaluating the usefulness of this element as an epidemiological tool.
One chromosomal region (RD1) was found to be present in 100% of M. tuberculosis clinical isolates and virulent laboratory strains (H37Rv and Erdman) but absent from all BCG substrains. This region encodes esat6 and seven additional ORFs, of which one may be a regulatory gene. The putative regulatory gene encoded within RD1 is apparently deleted from or nonfunctional in all BCG substrains. As determined by 2-D gel electrophoresis, the reintroduction of RD1 appears to strongly repress the expression of at least 10 proteins and downregulate the expression of many additional cellular proteins. The possible role of this regulation in the virulence of M. bovis and M. tuberculosis is under investigation. Although a definitive link between this apparent deletion and the attenuation of BCG has not been established, several possible rationales, based on our observations, are offered for this attenuation. One or more RD1 genes are directly involved in virulence, or one or more genes directly involved in the virulence of pathogenic mycobacteria may be regulated by an RD1-encoded gene. The lack of regulation due to a RD1 deletion results in the attenuated phenotype of BCG. This hypothesis is not without precedent, as the constitutive expression of phoP in S. typhimurium also results in an attenuated phenotype (4) . In BCG, the lack of tightly controlled expression of specific proteins may result in the display of a number of immunogenic proteins to the immune system, and an immune response to these proteins results in the clearance of the infection. Studies of 2-D gels and reporter genes indicate that several of these regulated proteins may be heat shock or stress proteins, and a protective immune response to heat shock proteins has been documented (42, 43) . The disrupted regulation of a stress response may also affect the ability to adapt and survive in the host and to cause disease. Higher levels of expression and the expression of additional proteins could also be due to a feedback mechanism caused by the loss of an RD1 gene(s). The mechanisms by which the RD1 mutation may cause these effects are under investigation.
Although a survey of clinical isolates clearly demonstrates that the intact RD1 is conserved in virulent tubercle bacilli, the possibility that RD1-encoded gene products have no role in virulence also exists. In a preliminary animal experiment, BCG::RD1 did not show enhanced in vivo growth in mice. However, in vivo growth rates among virulent tubercle bacilli vary widely and do not determine relative virulence, making it necessary to evaluate the pathology associated with infection (12) . Initial data indicate that the reintroduction of RD1 may affect BCG's ability to elicit pathology in a way similar to that of virulent M. bovis, but further study is necessary to more critically evaluate this effect (data not shown). The long and complex passage history of the BCG vaccine strain and subsequent substrain derivations make it likely that most BCG substrains carry multiple mutations, some of which could also affect in vivo growth and virulence. Repetitive passage under unchanging environmental conditions may have resulted in one or more mutations in regulatory function(s). The full res- VOL. 178, 1996 GENETIC DIFFERENCES BETWEEN BCG AND VIRULENT M. BOVIS 1281 on February 21, 2013 by PENN STATE UNIV http://jb.asm.org/ toration of virulence in BCG and the fulfillment of Koch's molecular postulates may require the repair of additional BCG mutations not detected in this study, and the restoration of RD1 may be one incremental step toward restoring virulence in BCG. Such information may be useful for the rational design of a more effective and defined live attenuated tuberculosis vaccine since it may be possible to improve the BCG vaccine incrementally by replacing defective genes encoding potentially protective antigens without restoring virulence. The identification of genetic differences between virulent tubercle bacilli and BCG could also lead to diagnostic tests which can discriminate between BCG immunization and infection with virulent tubercle bacilli. It is also hoped that the identification of critical genetic differences between virulent and avirulent mycobacteria of the tuberculosis complex will provide information about and insights into their pathogenic mechanisms, thus supplying a basis for the development of rational approaches and new treatments for tuberculosis.
